Pharmaceutical Business review

PacificGMP enters into agreement with BD Biosciences

The master cell bank and antibody manufacturing will be conducted in compliance with current good manufacturing practices standards. Master and working cell banks are a well-documented two-level storage system of mammalian cells. Cells from these banks may be used in production of biopharmaceuticals such as monoclonal antibodies, viral vectors or recombinant DNA products.

Leigh Pierce, president of PacificGMP, said: “We are pleased that BD Biosciences has chosen PacificGMP to perform mammalian cell banking and storage and antibody production under cGMP standards. PacificGMP is committed to the successful completion of this cell banking and antibody manufacturing project and to establishing a long-term development partnership with BD Biosciences.”